Similar Papers

Paper Title
Journal
Date
Author
Survival outcomes in older men with non-metastatic castration-resistant prostate cancer treated with androgen receptor inhibitors: a US Food and Drug Administration pooled analysis of patient-level data from three randomised trials.
Jaleh Fallah ...
The Lancet. Oncology | VOL. 22
Jaleh Fallah, et. al.Jaleh Fallah ...
01 Sep 2021
The real prevalence and clinical courses of non-metastatic castration-resistant prostate cancer: a retrospective single-institutional study.
Hajime Takamori ... Takashi Kobayashi
Japanese journal of clinical oncology | VOL. -
Hajime Takamori, et. al.Hajime Takamori ... Takashi Kobayashi
17 Jan 2025
The treatment landscape of nonmetastatic castrate resistant prostate cancer: A contemporary perspective
Brendan A Yanada ... Niall M Corcoran
Urologic Oncology: Seminars and Original Investigations | VOL. 42
Brendan A Yanada, et. al.Brendan A Yanada ... Niall M Corcoran
29 Mar 2024
Bone health effects of androgen-deprivation therapy and androgen receptor inhibitors in patients with nonmetastatic castration-resistant prostate cancer
Arif Hussain ... Andrea Mcnatty
Prostate Cancer and Prostatic Diseases | VOL. 24
Arif Hussain, et. al.Arif Hussain ... Andrea Mcnatty
07 Oct 2020
View more papers

More From: JCO precision oncology

Paper Title
Journal
Date
Author
Precision-Guided Durable Response From Venetoclax With Decitabine in a Patient With a Metastatic Refractory IDH2 -Mutant Cholangiocarcinoma
Eylül Özgü ... Mutlu Demiray
JCO Precision Oncology | VOL. -
Eylül Özgü, et. al.Eylül Özgü ... Mutlu Demiray
01 Feb 2025
Improving Individualized Rhabdomyosarcoma Prognosis Predictions Using Somatic Molecular Biomarkers
Mark Zobeck ... Philip J Lupo
JCO Precision Oncology | VOL. -
Mark Zobeck, et. al.Mark Zobeck ... Philip J Lupo
01 Feb 2025
Phase II Study of Copanlisib in Patients With PTEN Loss: Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols Z1G and Z1H
Mohamed A Gouda ... Keith T Flaherty
JCO Precision Oncology | VOL. -
Mohamed A Gouda, et. al.Mohamed A Gouda ... Keith T Flaherty
01 Feb 2025
Correlates of Cetuximab Efficacy in Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma Previously Treated With Immunotherapy.
Jong Chul Park ... Thomas J Roberts
JCO precision oncology | VOL. 9
Jong Chul Park, et. al.Jong Chul Park ... Thomas J Roberts
01 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.